Gilead Sciences Inc at Goldman Sachs Healthcare Conference Transcript
Great. Good morning, everyone. Thanks for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs, and we're really pleased to have Gilead with us. So we have Dan O'Day, Chairman and CEO; as well as Merdad Parsey, CMO.
Questions & Answers
To start here, maybe we'll start with some big picture questions. Can you just give us a 30,000-foot view of where the company stands today and where the challenges have been, the accomplishments and then how you think of kind of the forward from here?
' -
Sure. So first of all, Salveen, great to be here with Merdad, and we're delighted to share some updates on Gilead. So at the 30,000-foot level, I think Merdad and I would say that we're really pleased with what's happened over the past 4 years. I mean just to remind you what our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
